ARCHIVED: NOT AVAILABLE FOR CREDIT
Value-Based Pathology: The Northwell Experience



 

The rapid changes in American healthcare provide unprecedented opportunity for Pathology and Laboratory Medicine to create enhanced value for our services. Conversely, the threats to our diagnostic services (being commoditized and subjected to downward revenue pressure) are extreme. Both threats and opportunities will be examined, serving as a call for leadership by Pathologists and Laboratory Professionals alike. Examples from the Northwell Health Laboratories (formerly North Shore-LIJ Laboratories) will illustrate how Northwell is responding to these changing times.

Originally presented on February 18, 2016, in Salt Lake City, Utah.


Lecture Presenter

James M Crawford, MD, PhD

James M Crawford, MD, PhD

Professor and Chair of Pathology, Department of Pathology and Laboratory Medicine
Hofstra Northwell Health School of Medicine
Executive Director and Senior Vice President of Laboratory Services
Northwell Health

James M Crawford, MD, PhD, is Professor and Chair, Department of Pathology and Laboratory Medicine, Hofstra Northwell Health School of Medicine, and Executive Director and Senior Vice President of Laboratory Services, Northwell Health. He received his MD and PhD degrees from Duke University School of Medicine (1983), and his post-graduate training in Anatomic Pathology and Gastrointestinal Pathology at Brigham and Women's Hospital (1983-1987), followed by a Fellowship in Hepatic Pathology at the Royal Free Hospital in London (1989). He has served on faculty and as a staff pathologist at Harvard Medical School and Brigham and Women's Hospital (1988-1996), and the Yale University School of Medicine (1997-1999). From 1999-2008, he was Professor and Chair, Department of Pathology, Immunology and Laboratory Medicine at the University of Florida College of Medicine in Gainesville, FL. He has held his current position at North Shore-LIJ since January 2009. He has published extensively in Liver Physiology and Pathophysiology, Liver Pathology, and diseases of the alimentary tract. More recently, his scholarship and national leadership are in the realm of Patient Centered Care, Accountable Care, and Clinical Informatics. He is past-president of the Association of Pathology Chairs (APC) and Hans Popper Hepatopathology Society, past Editor-in-Chief of LABORATORY INVESTATION, an official journal of the US and Canadian Academy of Pathology (USCAP), and Editor-in-Chief of the new journal ACADEMIC PATHOLOGY, an official journal of the APC. He has served as Chair of the Council of Academic Societies of the Association of American Medical Colleges (AAMC), and on the AAMC Board of Directors. He is author of over 250 peer-review papers, critical reviews, book chapters, proceedings, and special publications, and senior editor of three books.


Objectives

After this presentation, participants will be able to:

  • Describe how the current Managed Care landscape is changing contractual relationships with providers of Pathology and Laboratory Medicine services.
  • Identify what market stakeholders are expecting from Pathology and Laboratory Medicine.
  • Apply strategies for responding to these market expectations.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories